Study on Prostate Cancer Treatment Using Hormone Therapy and Targeted Prostate Surgery

Inclusion Criteria

• Men with intermediate-risk prostate cancer, either favorable or unfavorable, based on specific medical criteria.
• No evidence of cancer spreading beyond the prostate or into the seminal vesicles, as confirmed by imaging tests.
• Must have chosen to undergo focal therapy for prostate cancer treatment.
• Confirmed non-metastatic prostate cancer through standard imaging tests for those with unfavorable intermediate-risk cancer.
• Men aged 18 years or older.
• Expected to live at least 10 more years, according to the treating doctor.
• In good general health, with a performance status score indicating ability to carry out daily activities.
• Fit for general anesthesia and the surgical procedure, with good visualization of the prostate on ultrasound and tolerance for the required positioning during surgery.
• Adequate organ and blood function, as shown by specific blood test results.
• Men with other cancers that do not interfere with the study treatment are eligible.
• Sexually active men must agree to use condoms and their partners must use effective contraception during and for three months after treatment.
• Must understand and agree to sign a consent form to participate in the study.

Exclusion Criteria

• Men who have had previous treatments for prostate cancer, such as surgery, radiation, or hormone therapy.
• Men with advanced prostate cancer that has spread to lymph nodes or other parts of the body.
• Men who cannot undergo MRI scans due to medical conditions or allergies.
• History of allergy to study drug components.
• History of removal of both testicles.
• Men with uncontrolled or severe illnesses.
• Men currently receiving or who have recently received other experimental treatments, unless approved by the study doctor.
• Men deemed unsuitable for the study by the treating doctor or unlikely to follow study procedures.